Two-dimensional Pd-based nanomaterials for bioapplications

Noble metal nanomaterials have been extensively explored in cancer diagnostic and therapeutic applica- tions owing to their unique physical and chemical properties, such as facile synthesis, straightforward surface functionalization, strong photothermal effect, and excellent biocompatibility. Herein...

Full description

Saved in:
Bibliographic Details
Published inScience bulletin Vol. 62; no. 8; pp. 579 - 588
Main Authors Chen, Xiaolan, Shi, Saige, Wei, Jingping, Chen, Mei, Zheng, Nanfeng
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 30.04.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Noble metal nanomaterials have been extensively explored in cancer diagnostic and therapeutic applica- tions owing to their unique physical and chemical properties, such as facile synthesis, straightforward surface functionalization, strong photothermal effect, and excellent biocompatibility. Herein, we summa- rize the recent development of two-dimensional (2D) Pd-based nanomaterials and their applications in cancer diagnosis and therapy. Different synthetic strategies for Pd nanosheets and the related nanostruc- tures, including Pd@Au, Pd@Ag nanoplates and mesocrystalline Pd nanocomlla, are first discussed. Together with their unique properties, the potential bioapplications of these 2D Pd nanomaterials are then demonstrated. With strong absorption in near-infrared (NIR) region, these nanomaterials have great potentials in cancer photothermal therapy (PTr). They also readily act as contrast agents in photoacoustic (PA) imaging or X-ray computed tomography (CT) to achieve image-guided cancer therapy. Moreover, significant efforts have been devoted to studying the combination of PTr and other treatment modalities (e.g., chemotherapy or photodynamic therapy) based on Pd nanomaterials. The remarkable synergistic or collaborative effects to achieve better therapeutic efficacy are discussed as well. Additionally, the biosaf- ety of 2D Pd-based nanomaterials in vitro and in vivo was evaluated. Finally, challenges for the applica- tions of Pd-based nanomaterials in cancer diagnosis and therapy, and future research prospects are highlighted.
Bibliography:Noble metal nanomaterials have been extensively explored in cancer diagnostic and therapeutic applica- tions owing to their unique physical and chemical properties, such as facile synthesis, straightforward surface functionalization, strong photothermal effect, and excellent biocompatibility. Herein, we summa- rize the recent development of two-dimensional (2D) Pd-based nanomaterials and their applications in cancer diagnosis and therapy. Different synthetic strategies for Pd nanosheets and the related nanostruc- tures, including Pd@Au, Pd@Ag nanoplates and mesocrystalline Pd nanocomlla, are first discussed. Together with their unique properties, the potential bioapplications of these 2D Pd nanomaterials are then demonstrated. With strong absorption in near-infrared (NIR) region, these nanomaterials have great potentials in cancer photothermal therapy (PTr). They also readily act as contrast agents in photoacoustic (PA) imaging or X-ray computed tomography (CT) to achieve image-guided cancer therapy. Moreover, significant efforts have been devoted to studying the combination of PTr and other treatment modalities (e.g., chemotherapy or photodynamic therapy) based on Pd nanomaterials. The remarkable synergistic or collaborative effects to achieve better therapeutic efficacy are discussed as well. Additionally, the biosaf- ety of 2D Pd-based nanomaterials in vitro and in vivo was evaluated. Finally, challenges for the applica- tions of Pd-based nanomaterials in cancer diagnosis and therapy, and future research prospects are highlighted.
2D nanomaterials;Palladium;Optical properties;Bioimaging;Photothermal therapy;Combination therapy
10-1298/N
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2095-9273
2095-9281
DOI:10.1016/j.scib.2017.02.012